Anti-MAGEA2/MAGEA2B antibody (50-130 aa) (STJ191701)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenSynthesized peptide derived from the human protein at the amino acid range 50-130
General Information
| Short Description | Rabbit polyclonal anti-Melanoma-associated antigen 2 (50-130 aa) for use in WB and ELISA in Human, Rat and Mouse samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | WB/ELISA |
| Host | Rabbit |
| Reactivity | Human/Rat/Mouse |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | 1 mg/mL |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Dilution Range | WB 1:500-2000ELISA 1:5000-20000 |
| Formulation | Liquid in PBS containing 50% Glycerol and 0.02% Sodium Azide. |
| Storage Instruction | Store at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Target Information
| Gene Symbol | MAGEA2.MAGEA2B |
| Gene ID | 266740/4101 |
| Uniprot ID | MAGA2_HUMAN |
| Immunogen | Synthesized peptide derived from the human protein at the amino acid range 50-130 |
| Immunogen Region | 50-130 aa |
| Specificity | MAGA2 Polyclonal Antibody detects endogenous levels of protein. |
Additional Info
| Function | Reduces p53/TP53 transactivation function through recruitment of HDAC3 to p53/TP53 transcription sites. Also represses p73/TP73 activity. Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. In vitro enhances ubiquitin ligase activity of TRIM28 and stimulates p53/TP53 ubiquitination by TRIM28 potentially in presence of Ubl-conjugating enzyme UBE2H. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. Negatively regulates acetylation and sumoylation of PML and represses PML-induced p53/TP53 acetylation and activation. |
| Protein Name | Melanoma-Associated Antigen 2Cancer/Testis Antigen 1.2Ct1.2Mage-2 Antigen |
| Database Links | |
| Cellular Localisation | NucleusPml Body |
| Alternative Antibody Names | Anti-Melanoma-Associated Antigen 2 antibodyAnti-Cancer/Testis Antigen 1.2 antibodyAnti-Ct1.2 antibodyAnti-Mage-2 Antigen antibodyAnti-MAGEA2 antibodyAnti-MAGE2 antibodyAnti-MAGEA2A.MAGEA2B antibodyAnti-MAGE2 antibodyAnti-MAGEA2 antibody |
Information sourced from Uniprot.org